("Helium One" or the "Company")
Galactica Development Update
Highlights
· Construction has commenced on the production facility pad and gathering system
· First helium production on schedule for
Details
Site works are underway for the 120m x 150m production facility pad and concurrent upgrade of the immediate access road, which will prepare the site for the delivery and installation of production equipment. The procurement and delivery of all major production components is proceeding on schedule.
The gathering system is designed to incorporate future infill and expansion wells and will include taps and risers set for connection of future wells. Construction is starting at
The Company remains on schedule to deliver first helium in December and first CO2 for sale in H1 2026. The Galactica Pinon


For further information please visit the Company's website: www.helium-one.com
|
|
+44 20 7920 3150 |
|
|
|
|
|
|
|
|
+44 20 3100 2000 |
|
|
|
|
|
+44 20 3829 5000
|
|
|
|
|
Tavistock (Financial PR)
|
+44 20 7920 3150
|
|
|
|
|
|
|
Notes to Editors
The Company's flagship southern Rukwa Project is located within the southern Rukwa Rift Basin in south-west
Following the success of the EWT, the Company filed a
The Company also owns a 50% working interest in the Galactica-Pegasus helium development project in
This programme has seen a systematic approach to developing the extensive Lyons Formation reservoir. The programme has delivered encouraging results, in line with expectations, consistently encountering good helium (up to 3.3% He) and CO2 concentrations in the target formation and demonstrating promising flow potential. The next steps will see the Galactica wells tied into initial production in Q4 2025.
Helium One is listed on the AIM market of the London Stock Exchange with the ticker of HE1.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the